ZEB1 and breast cancer: By mediating the asymmetric dimethylation of histone H4R3 residue within the ZEB1 (zinc finger E homeobox-binding 1) promoter, PRMT1 activates ZEB1 expression and induces EMT in BC cells [23] (Figure 2).